Implementation of patient-reported outcome measures into health care for men with localized prostate cancer.
Udit SinghalTed A SkolarusJohn L GoreMatthew G ParryRonald C ChenJulie NossiterAlan Paniagua-CruzArvin K GeorgePaul CathcartJan van der MeulenDaniela A WittmannPublished in: Nature reviews. Urology (2022)
Measuring treatment-related quality of life (QOL) has become an increasingly requisite component of delivering high-quality care for patients with prostate cancer. Patient-reported outcome measures (PROMs) have, therefore, become an important tool for understanding the adverse effects of radical prostate cancer treatment and have been widely integrated into clinical practice. By providing real-time symptom monitoring and improved clinical feedback to patients and providers, PRO assessment has led to meaningful gains in prostate cancer care delivery and quality improvement worldwide. By providing an avenue for benchmarking, collaboration and population health monitoring, PROMs have delivered substantial improvements beyond providing individual symptom feedback. However, multilevel barriers exist that need to be addressed before the routine implementation of PROMs is achieved. Improvements in collection, interpretation, standardization and reporting will be crucial for the continued implementation of PROM instruments in prostate cancer pathways.
Keyphrases
- patient reported outcomes
- prostate cancer
- quality improvement
- patient reported
- healthcare
- radical prostatectomy
- clinical practice
- patient safety
- primary care
- palliative care
- adverse drug
- emergency department
- newly diagnosed
- pain management
- prognostic factors
- affordable care act
- chronic kidney disease
- anti inflammatory
- electronic health record